Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
FOXO4-DRI enters senescent cells and competitively binds to p53 through its modified peptide sequence, displacing endogenous FOXO4 and freeing p53 to activate cell death pathways including BAX and PUMA
Its primary, celebrated mechanism is tissue regeneration and repair
When considering BPC 157, it is critical to consult with a healthcare provider to ensure its appropriateness for individual needs
We dont have the quality human trials that we need to give us a clear understanding of the best ways to use this peptide, what it could treat, and whether its safe
Salehi Z, Rajaei F
US$ 21.75
US$ 22.57
US$ 21.97
US$ 20.18
US$ 22.56
US$ 24.61
